Thomé, Carolina Hassibe 
; Ferreira, Germano Aguiar ; Martins, Diego Antonio Pereira ; Santos, Guilherme Augusto dos; Ortiz, César Alexander; Souza, Lucas Eduardo Botelho de ; Sobral, Lays Martins; Silva, Cleide Lúcia Araújo; Scheucher, Priscila Santos ; Gil, Cristiane Damas; Leopoldino, Andréia Machado ; Silveira, Douglas Rafaele Almeida ; Silva, Juan Luiz Coelho da ; Traina, Fabiola ; Koury, Luisa C.; Melo, Raul A. M.; Bittencourt, Rosane; Pagnano, Katia; Pasquini, Ricardo; Nunes, Elenaide C.; Fagundes, Evandro M.; Gloria, Ana Beatriz F.; kerbauy, Fábio Rodrigues; Chauffaille, Maria de Lourdes; Keating, Armand; Tallman, Martin S.; Ribeiro, Raul C.; Dillon, Richard; Ganser, Arnold; Löwenberg, Bob; Valk, Peter; Lo-Coco, Francesco; Sanz, Miguel A.; Berliner, Nancy; Faça, Vitor Marcel ; Rego, Eduardo Magalhaes
Fonte: Scientific Reports. Unidades: FMRP, FCFRP, FM
Assuntos: PROTEÍNAS, TRANSDUÇÃO DE SINAL CELULAR, QUIMIOTERAPIA, ANTINEOPLÁSICOS, MEDULA ÓSSEA, DIFERENCIAÇÃO CELULAR, SOBREVIVÊNCIA CELULAR, LEUCEMIA, FARMACOTERAPIA, ANÁLISE DE SOBREVIVÊNCIA, ESTUDOS RETROSPECTIVOS
ABNT
THOMÉ, Carolina Hassibe et al. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports, v. 10, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-66223-2. Acesso em: 17 maio 2024.APA
Thomé, C. H., Ferreira, G. A., Martins, D. A. P., Santos, G. A. dos, Ortiz, C. A., Souza, L. E. B. de, et al. (2020). NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia. Scientific Reports, 10( 1). doi:10.1038/s41598-020-66223-2NLM
Thomé CH, Ferreira GA, Martins DAP, Santos GA dos, Ortiz CA, Souza LEB de, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Silva JLC da, Traina F, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria ABF, kerbauy FR, Chauffaille M de L, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Faça VM, Rego EM. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia [Internet]. Scientific Reports. 2020 ; 10( 1):[citado 2024 maio 17 ] Available from: https://doi.org/10.1038/s41598-020-66223-2Vancouver
Thomé CH, Ferreira GA, Martins DAP, Santos GA dos, Ortiz CA, Souza LEB de, Sobral LM, Silva CLA, Scheucher PS, Gil CD, Leopoldino AM, Silveira DRA, Silva JLC da, Traina F, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria ABF, kerbauy FR, Chauffaille M de L, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk P, Lo-Coco F, Sanz MA, Berliner N, Faça VM, Rego EM. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia [Internet]. Scientific Reports. 2020 ; 10( 1):[citado 2024 maio 17 ] Available from: https://doi.org/10.1038/s41598-020-66223-2
